Epinephrine: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==General==
*Type: [[Vasopressors]]
*Dosage Forms:
*Common Trade Names:
==Adult Dosing==
==Pediatric Dosing==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*Lactation:
*Renal Dosing
**Adult
**Pediatric
*Hepatic Dosing
**Adult
**Pediatric
==Contraindications==
*Allergy to class/drug
==Adverse Reactions==
===Serious===
===Common===
==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:
*Mechanism of Action:
==See Also==
==Sources==
<references/>
[[Category:Drugs]]
==Concentration==
==Concentration==
*Amount of solution in mL used to dilute 1,000mg of epinephrine
*Amount of solution in mL used to dilute 1,000mg of epinephrine

Revision as of 14:35, 20 December 2014

General

Adult Dosing

Pediatric Dosing

Special Populations

  • Pregnancy Rating:
  • Lactation:
  • Renal Dosing
    • Adult
    • Pediatric
  • Hepatic Dosing
    • Adult
    • Pediatric

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

See Also

Sources


Concentration

  • Amount of solution in mL used to dilute 1,000mg of epinephrine
    • eg 1:10,000 = 1,000mg/10,000mL = 0.1mg/mL

Adult Dosing

Anaphylaxis

0.3-0.5mg of 1:1,000 IM

  • Consider glucagon 1-5mg IV if pt on B-blockers and not responding to epi

Anaphylactic shock

0.1mg of 1:10,000 slow IV during 5 min, can start infusion of 1-4 mcg/min

Cardiac Arrest

1mg of 1:10,000 IVP

Pediatric Dosing

See critical care quick reference for drug doses by weight.

See Also

Pressor

Indication

  • Anaphylaxis

Primary Receptor

  • β1
  • α1
  • β2

Relative Effects

  • ↑↑↑HR
  • ↑↑↑SV
  • ↑↑↑SVR
  • Bronchodilation (β2)

Dosing

  • Dose-dependent effects:
  • 1-10 mcg/min - increase HR and SV
  • 10-20 mcg/min - increase SVR

Rate of Titration

  • Q2-5 min

Adverse Effects

  • Tachyarrhythmias
  • Myocardial ischemia
  • ↑Serum lactate
  • Splanchnic ischemia

Notes

  • ↑lactate occurs primarily from ↑glycolysis/glycogenolysis within skeletal muscles not tissue hypoperfusion
  • Use with caution in pts with CAD
    • However clinical trials have not demonstrated worsened outcomes